• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

预测美国癌症联合委员会(AJCC)I/II期原发性皮肤黑色素瘤前哨淋巴结状态。

Predicting sentinel node status in AJCC stage I/II primary cutaneous melanoma.

作者信息

Kruper Laura L, Spitz Francis R, Czerniecki Brian J, Fraker Douglas L, Blackwood-Chirchir Anne, Ming Michael E, Elder David E, Elenitsas Rosalie, Guerry Dupont, Gimotty Phyllis A

机构信息

Melanoma Program of the Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.

出版信息

Cancer. 2006 Nov 15;107(10):2436-45. doi: 10.1002/cncr.22295.

DOI:10.1002/cncr.22295
PMID:17058288
Abstract

BACKGROUND

Sentinel lymph node (SLN) status is an important prognostic factor for survival for patients with primary cutaneous melanoma. To address the issue of selecting patients at high and low risk for a positive SLN, prognostic factors were sought that predict SLN involvement by examining characteristics of both the primary tumor and the patient within the context of a biological model of melanoma progression.

METHODS

The study included 682 patients with primary vertical growth phase (VGP) melanoma and no clinical evidence of metastatic disease who underwent SLN biopsy (1995-2003). Logistic regression and classification tree analyses were used to investigate the association between SLN positivity and Breslow thickness, Clark level, tumor infiltrating lymphocytes (TIL), ulceration, mitotic rate (MR), lesion site, gender, and age. RESULTS.: In all, 88 of the 682 patients had > or =1 positive SLN (12.9%). In the multivariate analysis, MR, TIL, and thickness were found to be independent prognostic factors for SLN positivity. In the classification tree, four different risk groups were defined, ranging from minimal risk (2.1%) to high risk (40.4%). In lesions < r =2.0 mm, MR was important in risk-stratifying patients, and in lesions >2.0 mm TIL was important.

CONCLUSIONS

By incorporating biologically based variables such as VGP, TIL, and MR along with thickness into a prognostic model, both patients at high risk and minimal risk for SLN positivity can be identified. If validated, this model can be used in patient management and trial design to select patients to undergo or be spared SLN biopsy.

摘要

背景

前哨淋巴结(SLN)状态是原发性皮肤黑色素瘤患者生存的重要预后因素。为了解决选择SLN阳性高风险和低风险患者的问题,通过在黑色素瘤进展的生物学模型背景下检查原发性肿瘤和患者的特征,寻找预测SLN受累的预后因素。

方法

该研究纳入了682例原发性垂直生长期(VGP)黑色素瘤且无转移疾病临床证据的患者,这些患者接受了SLN活检(1995 - 2003年)。采用逻辑回归和分类树分析来研究SLN阳性与Breslow厚度、Clark分级、肿瘤浸润淋巴细胞(TIL)、溃疡、有丝分裂率(MR)、病变部位、性别和年龄之间的关联。

结果

682例患者中,共有88例患者有≥1枚SLN阳性(12.9%)。在多变量分析中,MR、TIL和厚度被发现是SLN阳性的独立预后因素。在分类树中,定义了四个不同的风险组,从最低风险(2.1%)到高风险(40.4%)。在r≤2.0 mm的病变中,MR在患者风险分层中很重要,而在病变>2.0 mm时,TIL很重要。

结论

通过将基于生物学的变量如VGP、TIL和MR以及厚度纳入预后模型,可以识别出SLN阳性的高风险和最低风险患者。如果得到验证,该模型可用于患者管理和试验设计,以选择接受或免于SLN活检的患者。

相似文献

1
Predicting sentinel node status in AJCC stage I/II primary cutaneous melanoma.预测美国癌症联合委员会(AJCC)I/II期原发性皮肤黑色素瘤前哨淋巴结状态。
Cancer. 2006 Nov 15;107(10):2436-45. doi: 10.1002/cncr.22295.
2
Clinical and histopathological risk factors to predict sentinel lymph node positivity, disease-free and overall survival in clinical stages I-II AJCC skin melanoma: outcome analysis from a single-institution prospectively collected database.预测美国癌症联合委员会(AJCC)临床I-II期皮肤黑色素瘤前哨淋巴结阳性、无病生存期和总生存期的临床及组织病理学危险因素:来自单机构前瞻性收集数据库的结果分析
Eur J Cancer. 2009 Sep;45(14):2537-45. doi: 10.1016/j.ejca.2009.05.034. Epub 2009 Jun 22.
3
Tumor-infiltrating lymphocytes predict sentinel lymph node positivity in patients with cutaneous melanoma.肿瘤浸润淋巴细胞可预测皮肤黑色素瘤患者前哨淋巴结转移情况。
J Clin Oncol. 2007 Mar 1;25(7):869-75. doi: 10.1200/JCO.2006.08.9755.
4
Lymphatic invasion identified by monoclonal antibody D2-40, younger age, and ulceration: predictors of sentinel lymph node involvement in primary cutaneous melanoma.通过单克隆抗体D2-40鉴定的淋巴管侵犯、较年轻的年龄以及溃疡:原发性皮肤黑色素瘤前哨淋巴结受累的预测因素。
Arch Dermatol. 2008 Apr;144(4):462-7. doi: 10.1001/archderm.144.4.462.
5
The sentinel lymph node status is an important factor for predicting clinical outcome in patients with Stage I or II cutaneous melanoma.前哨淋巴结状态是预测Ⅰ期或Ⅱ期皮肤黑色素瘤患者临床结局的重要因素。
Cancer. 2001 Jun 15;91(12):2401-8.
6
Should all patients with melanoma between 1 and 2 mm Breslow thickness undergo sentinel lymph node biopsy?1-2 毫米 Breslow 厚度的所有黑色素瘤患者都应该进行前哨淋巴结活检吗?
Cancer. 2010 Mar 15;116(6):1535-44. doi: 10.1002/cncr.24895.
7
The impact of factors beyond Breslow depth on predicting sentinel lymph node positivity in melanoma.除 Breslow 深度之外的因素对预测黑色素瘤前哨淋巴结阳性的影响。
Cancer. 2007 Jan 1;109(1):100-8. doi: 10.1002/cncr.22382.
8
American Joint Committee on Cancer clinical stage as a selection criterion for sentinel lymph node biopsy in thin melanoma.美国癌症联合委员会临床分期作为薄型黑色素瘤前哨淋巴结活检的选择标准。
Ann Surg Oncol. 2006 Feb;13(2):198-204. doi: 10.1245/ASO.2006.03.092. Epub 2006 Jan 19.
9
Mitotic rate as a predictor of sentinel lymph node positivity in patients with thin melanomas.有薄型黑色素瘤患者的有丝分裂率作为前哨淋巴结阳性的预测指标
Ann Surg Oncol. 2005 Jun;12(6):449-58. doi: 10.1245/ASO.2005.04.027. Epub 2005 Apr 19.
10
Prediction of non-sentinel node status and outcome in sentinel node-positive melanoma patients.前哨淋巴结阳性黑色素瘤患者非前哨淋巴结状态及预后的预测
Eur J Surg Oncol. 2008 Jan;34(1):82-8. doi: 10.1016/j.ejso.2007.01.027. Epub 2007 Mar 13.

引用本文的文献

1
Tumor-infiltrating lymphocytes as a prognostic and predictive factor for Melanoma.肿瘤浸润淋巴细胞作为黑色素瘤的预后和预测因素
Expert Rev Mol Diagn. 2024 Apr;24(4):299-310. doi: 10.1080/14737159.2024.2312102. Epub 2024 Feb 5.
2
Prognostic Significance of Primary Tumor-Infiltrating Lymphocytes in a Contemporary Melanoma Cohort.原发性肿瘤浸润淋巴细胞对当代黑色素瘤队列的预后意义。
Ann Surg Oncol. 2022 Aug;29(8):5207-5216. doi: 10.1245/s10434-022-11478-4. Epub 2022 Mar 17.
3
Is There a Relationship Between TILs and Regression in Melanoma?
肿瘤浸润淋巴细胞与黑色素瘤消退之间存在关系吗?
Ann Surg Oncol. 2022 May;29(5):2854-2866. doi: 10.1245/s10434-021-11251-z. Epub 2022 Jan 21.
4
Role of Biomarkers in the Integrated Management of Melanoma.生物标志物在黑色素瘤综合管理中的作用。
Dis Markers. 2021 Dec 30;2021:6238317. doi: 10.1155/2021/6238317. eCollection 2021.
5
Integrating 31-Gene Expression Profiling With Clinicopathologic Features to Optimize Cutaneous Melanoma Sentinel Lymph Node Metastasis Prediction.整合 31 基因表达谱与临床病理特征以优化皮肤黑色素瘤前哨淋巴结转移预测。
JCO Precis Oncol. 2021 Sep 13;5. doi: 10.1200/PO.21.00162. eCollection 2021.
6
Unraveling the Wide Spectrum of Melanoma Biomarkers.解析黑色素瘤生物标志物的广泛谱系
Diagnostics (Basel). 2021 Jul 26;11(8):1341. doi: 10.3390/diagnostics11081341.
7
Molecular analysis of primary melanoma T cells identifies patients at risk for metastatic recurrence.原发性黑色素瘤 T 细胞的分子分析可识别有转移复发风险的患者。
Nat Cancer. 2020 Feb;1(2):197-209. doi: 10.1038/s43018-019-0019-5. Epub 2020 Jan 20.
8
The neutrophil-lymphocyte ratio and locoregional melanoma: a multicentre cohort study.中性粒细胞-淋巴细胞比值与局部区域黑色素瘤:一项多中心队列研究。
Cancer Immunol Immunother. 2020 Apr;69(4):559-568. doi: 10.1007/s00262-019-02478-7. Epub 2020 Jan 23.
9
Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non-Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain Tumors.评估实体瘤中的肿瘤浸润淋巴细胞:病理学家实用综述及国际免疫肿瘤生物标志物工作组提出的标准化方法建议:第 2 部分:黑色素瘤、胃肠道癌、非小细胞肺癌和间皮瘤、子宫内膜癌和卵巢癌、头颈部鳞状细胞癌、泌尿生殖道癌和脑原发性肿瘤中的 TILs。
Adv Anat Pathol. 2017 Nov;24(6):311-335. doi: 10.1097/PAP.0000000000000161.
10
Regression in primary cutaneous melanoma: etiopathogenesis and clinical significance.原发性皮肤黑色素瘤的消退:病因发病机制及临床意义。
Lab Invest. 2017 Jun;97(6):657-668. doi: 10.1038/labinvest.2017.8. Epub 2017 Feb 27.